Multi-fraction radiation improves outcomes for brain metastases
Stereotactic radiation delivered over three to five sessions after surgery significantly improved local control for patients with large, resected brain metastases compared with single fraction treatment.
Results from the first randomized phase 3 trial comparing differing radiation schedules, presented at American Society for Radiation Oncology Annual Meeting, also showed an association with a 9-month survival benefit for patients who received treatment over multiple visits.
“This was a positive trial with a clear message: Fractionated stereotactic radiation should now be considered a standard